Skip to main content

Table 1 Summary of clinical data from 41 consecutive patients with BM from SCLC

From: Upfront stereotactic radiosurgery in patients with brain metastases from small cell lung cancer: retrospective analysis of 41 patients

Characteristics

Values

Sex (male/female)

34 / 7

Age (years), median (range)

69 (50–85)

KPS, median (range)

90 (30–100)

Active Extra-CNS disease or Extra-CNS metastasis

25 (61%)

DS-GPA 0–1.0/1.5-2.5/3.0-4.0

20 / 15 / 6

RTOG-RPA class I/class II/class III

6 / 25 / 10

Post-SRS chemotherapy

32 (78%)

Time from primary diagnosis to initial SRS (months), median (range)

7.8 (0.3-149)

Cumulative PTV on initial SRS (mL), median (range)

3.8 (0.6-28.2)

No. of intracranial lesions on initial SRS, median (range)

2 (1–10)

  1. BM: brain metastases, SCLC: small cell lung cancer, KPS: Karnofsky performance status, CNS: central nervous system, DS-GPA: diagnosis-specific graded prognostic assessment, RTOG-RPA radiation treatment oncology group recursive partitioning analysis, , SRS: stereotactic radiosurgery, PTV: planning target volume.